about
Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantationTreatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation.Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs.Portal vein thrombosis and liver transplantation: implications for waiting list period, surgical approach, early and late follow-up.Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.Acute Liver Failure in an Adult, a Rare Complication of Alagille Syndrome: Case Report and Brief Review.Obesity as predictor of postoperative outcomes in liver transplant candidates: Review of the literature and future perspectives.Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer.Enteric-coated mycophenolate sodium: one-way conversion from mycophenolate mofetil and de novo use in stable liver transplant recipients.Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation.Safety of long-term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection.The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor.A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy.Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.Can we match donors and recipients in a cost-effective way?Factors predicting ischemic-type biliary lesions (ITBLs) after liver transplantation.Donor-recipient MELD-based match in a patient who required three liver grafts in the era of nonstandard donors: case report.Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West.Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued?Use of an esophageal echo-Doppler device during liver transplantation: preliminary report.Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma.Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival.http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation.Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match.The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient.Prediction of 6-month survival after liver transplantation using Cox regression.Graft steatosis as a risk factor of ischemic-type biliary lesions in liver transplantationCombination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantationRole of Alpha-Fetoprotein in Selection of Patients with Hepatocellular Carcinoma Waiting for Liver Transplantation: Must we Reconsider it?ABO Blood Group-Related Waiting List Disparities in Liver Transplant Candidates: Effect of the MELD AdoptionPostoperative respiratory failure in liver transplantation: Risk factors and effect on prognosisEnzymatic determinations in acute rejection after liver transplantation: preliminary report on necrosis indexPulmonary gas exchange during orthotopic liver transplantationSuccessful transplantation of an injured liverCeliac axis compression syndrome in liver transplantationPrimary dysfunction after liver transplantation: donor or recipient fault?Outcome of liver transplantation after acute rejection and sepsisPosttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient seriesSuccessful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27Late development of splenic artery aneurysm after orthotopic liver transplantation: a case report
P50
Q26852105-70924017-3FB1-4A7B-978B-40E0BE158356Q33380587-7384228B-3A18-45EC-BFAC-7F3486D798BCQ34953849-99F6B09A-7ACB-46B8-AB9C-AAA6C68ED661Q38192256-A6769D26-A77D-4838-AE67-9316FA876F48Q38482166-29EDE87E-3C02-4707-9DE2-207EF63405E9Q38585071-FDC42968-324D-44EA-8E13-FC2C3D955FADQ38628389-C4C31B2D-4496-4AEB-9114-4D7072D44133Q38707454-72DB8954-4C42-467C-BD7C-616EDFDB9B87Q39303356-25CE04A1-ED26-4EC9-A02B-84F7B70870E2Q40548605-3D855408-B966-43A1-B9DD-6B37472B069CQ41526311-AC17E327-5E65-45DB-8A29-179113C81CBBQ42668851-9C68C53F-674A-41BB-AC25-083ECC4988F3Q43037220-2DB924B5-7749-4825-9A32-DE7B49B2476AQ43841473-51470823-4014-4D3F-AEC9-884B89331479Q44586834-9733DCBE-2F6D-4D3E-A59A-88E49CA7010EQ44884223-67C65D3C-4914-4988-AE5E-F67B842ACEBDQ45893568-30DC2BE6-FE01-42FC-861F-516EBB5B8588Q47409716-F1739506-FBEA-412E-8F8C-CA883482989AQ48334848-0404E1BC-B0E2-40C1-8C65-799F9D972A74Q48444965-01D72A4A-B69D-44D7-BE12-D31DC1D31A0BQ49164405-2C019779-DB83-4FA2-B208-6CBEA0986635Q50607926-4D5E2C96-11EC-4808-951C-A2194D58408EQ51440305-E3E401F6-1BE3-4C9E-8C03-1AF3CA5780C3Q51784933-12BEA3C9-0A14-4C86-9074-64A0C52F6E49Q51940417-42978BB2-EFA3-4A36-B4BD-28A2E7DB0E2CQ51998667-D53D6020-1E99-40B1-8093-8C4C1C94BBFAQ57150533-EE856976-E7C5-4BA0-B916-35E9F0A61062Q57792485-E9003AEF-5E4B-4E38-BFA8-8801DBAA9926Q57792511-ABBF71D8-E56A-4E64-905C-5EC0970CBBD5Q62804357-70E1E5BD-BB60-4A17-B9BB-896C5B8A6722Q64235488-01FC19B1-7082-4B63-80BA-0710F14BABADQ70658112-58DC6802-DBFF-43A3-8FE9-6348F4BC7668Q72421965-750DA8C1-69CF-4D5D-8EC8-6867DDD647DDQ73506845-579C42D1-3826-4D35-85F7-5E50B3B06469Q73669054-E52F7C03-B5F6-4BF9-A3EE-907257CC1ABCQ74616241-8FFB3631-F878-43E9-894F-A5A2C34786BEQ77724889-FEF2B514-1BC9-41EB-9A93-EB665E0BC28DQ80783395-00E00CAB-5E0D-4403-A70F-1696D1274B9EQ83401667-36BFC9FC-1861-4A7B-A7BF-FEFF3AA29B2BQ83879908-EBED9265-81D8-4058-857D-540611AE04F4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alfonso W Avolio
@ast
Alfonso W Avolio
@en
Alfonso W Avolio
@es
Alfonso W Avolio
@nl
type
label
Alfonso W Avolio
@ast
Alfonso W Avolio
@en
Alfonso W Avolio
@es
Alfonso W Avolio
@nl
prefLabel
Alfonso W Avolio
@ast
Alfonso W Avolio
@en
Alfonso W Avolio
@es
Alfonso W Avolio
@nl
P106
P1153
7006686265
P31
P496
0000-0003-2491-7625